Thermo Fisher Scientific Inc. (TMO)

306.81
NYSE : Health Technology
Prev Close 300.84
Day Low/High 302.50 / 306.95
52 Wk Low/High 208.34 / 306.00
Avg Volume 1.41M
Exchange NYSE
Shares Outstanding 400.99M
Market Cap 120.63B
EPS 7.30
P/E Ratio 33.84
Div & Yield 0.76 (0.25%)
Go All-In On Actavis, Visa

Go All-In On Actavis, Visa

Chase Growth Fund portfolio manager Edward Painvin names his favorite stocks including Visa, Actavis, Thermo Fisher and Precision Castparts.

USAA: AbbVie, Google Offer Growth

USAA: AbbVie, Google Offer Growth

John Toohey, PM of the USAA First Start Growth Fund, names his top stocks including AbbVie, Thermo Fisher, Google and Texas Instruments.

Thermo Fisher estimates reduced at UBS

Thermo Fisher upgraded at Mizuho

Citi Beats, Thermo Fisher's $13.6B Deal

Citi Beats, Thermo Fisher's $13.6B Deal

Banking giant Citigroup topped Wall Street forecasts by six cents a share on stronger securities and investment banking revenue. TheStreet's Brittany Umar has details from New York.

An Agile Rebound on the Horizon

An Agile Rebound on the Horizon

This recent laggard looks set for a turnaround, making it a good value at current levels.

Thermo Fisher upgraded at JP Morgan

Staying Wary on Bruker

Staying Wary on Bruker

Its CEO buys more shares, but some of the company's peers trade at better P/E multiples.

Two Robust Defensive Plays to Consider

Two Robust Defensive Plays to Consider

In the healthcare sector, TMO and TEVA are well positioned to ride out the market's current volatility.

Thermo Fisher upgraded at Wells

Warming Up to Thermo Fisher

Warming Up to Thermo Fisher

This is a great opportunity to buy a stable growth stock at a discounted price.

An Astounding Value Once More

An Astounding Value Once More

Here's your second shot at Thermo Fisher, which has followed the market down to bargain prices.

Thermo Fisher downgraded at Mizuho

Thermo Fisher rated new Buy at Cantor

A Diamond Out of the Wreckage

A Diamond Out of the Wreckage

After Wednesday's selloff, this very healthy growth name is selling for cheap.

Thermo Fisher downgraded at Goldman